For Veterinary Use Only With a Prescription.
NAVET-CEL is a veterinary antibiotic injection that contains Ceftifor as an active ingredient. The ideal solution for treating mastitis, foot-and-mouth disease, pneumonia in cattle, goats & sheep. Find out more information about the product on Byttara.com..
Quantitative and qualitative ingredients:
Each ml NAVET-CEL contains:
Active substance:
Ceftiofur (as Ceftiofur hydrochloride)…50mg
BHT….10mg
Indications:
NAVET-CEL is used for treatment of Cattle, Sheep and Goat Pasteurellosis, Pneumonia, Metris, Mastitis, Salmonellosis & foot rot.
Contraindications:
Don’t administer NAVET-CEL to an a previously found to be hypersensitive to ceftiofur and B-lactam antibiotics or to any of the excipients.
Do not use in case of known resistance to the active substance or to beta-lactam antibiotics.
Do not inject intravenously.
Do not use it in poultry (including eggs) due to risk of spreading antimicrobial resistance to humans.
Adverse reactions:
In Cattle, mild inflammatory reaction at the injection site by NAVET-CEL , such as tissue oedema, discoloration of the subcutaneous tissue and/or fascial surface of the muscle may be observed. Clinical resolution reached in most animals by 10 days after injection although slight tissue discoloration may persist for 28 days or Hypersensitivity reactions unrelated to dose can occur Allergic reactions (e.g. skin reactions, anaphylaxis) occasionally occur.
In case of the occurrence of an allergic reaction the treatment should be withdrawn.
Target species:
Cattle, Sheep and Goats.
Dosage and administration:
Shake well before use.
NAVET-CEL is administered by intramuscular or subcutaneous injections: 1-2 ml/50 kg body weight/day.
Using within 3 successive days.
Withdrawal period:
For meat: Cattle, Sheep and Goats: 4 days.
For milking: 0 day.
Special storage conditions:
NAVET-CEL requires keeping at room temperature below 25 c.
Do not use after the expiry date stated on the carton.
Shelf life after first broaching of the container: 28 days Keep the vial in the outer carton in order to protect from light.
Special warning(s):
Special precautions for use in animals:
NAVET-CEL selects for resistant strains such as bacteria carrying extended spectrum beta lactamases (ESBL) and may constitute a risk to human health if these strains disseminate to humans e.g. via food.
For this reason NAVET-CEL should be reserved for the treatment of clinical conditions which have responded poorly, or are expect respond poorly (refers to very acute cases when treatment
must be initiated without bacteriological diagnosis) to first line treatment.
Official, national and regional antimicrobial policies should be taken into account when the product is used. Increased use, including use of the product deviating from the instructions given, may increase the prevalence of such resistance.
Whenever possible, the product should only be used based on susceptibility testing. The product is intended for treatment of individual animals.
Do not use it for disease prevention or as a part of herd health programmes.
Treatment of groups of animals should be strictly restricted to ongoing disease outbreaks according to the approved conditions of use.
Do not use it as prophylaxis in case of retained placenta.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa.
Allergic reactions to these substances may occasionally be serious. In case of hypersensitivity or if you have been warned not to use these products any contact with the product should be avoided. Take care to avoid accidental self-injection. In the case of self-injection or following exposure and development of symptoms such as skin rash, seek medical advice immediately and show the package leaflet to the physician. Swelling of the face, lips or eyes or
difficulty with breathing are more serious symptoms and require urgent medical attention.
Overdose:
In Cattle, no signs of systemic toxicity have been observed following substantial parenteral overdosages.
Incompatibilities:
In the absence of compatibility studies, NAVET-CEL should not be mixed with other veterinary medicinal products.
Use during pregnancy and lactation:
Studies in laboratory species have not produced any evidence of teratogenic, fetotoxic or materno toxic effects or of abortion.
Reviews
There are no reviews yet.